Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Texas Heart Institute designates this educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Estimated Study Time
The estimated time to complete this activity, including review of the materials and completion of the course assessment is 4 hours.
If you previously completed and received credit for the live CME-sponsored symposium entitled, Emerging Trends in the Management of Arrhythmias and Pump Failure in Patients with Advanced Herat Failure on February 6-7, 2009, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even in order to validate learning or to clarify specific topics, cannot claim, nor will the Texas Heart Institute award, duplicate credit for the activity.
Term of Approval
March 12, 2009 through March 12, 2012. Continuation of CME credit from March 12, 2012 depends upon a thorough review of the content for currency and accuracy.
In March 2009, this continuing medical education activity was reviewed for currency and accuracy of content by Patrick J. Hogan, MD, FACC, Director Learning Resource Center and Co-Chairman, Medical Education Committee, Texas Heart Institute, Houston, TX.
Disclosure of Relationships
It is the intent of the Texas Heart Institute to ensure that its educational mission and its continuing medical activities in particular, should not be influenced by the special interests of individuals associated with its program.
In accordance with the guidelines of the Accreditation Council for Continuing Medical Education, faculty members have disclosed their relationships, either with one or more of the manufacturers of commercial products discussed, or with one or more of the corporate organizations offering educational grants for the live continuing medical education activity.
Richard Abben, MD does not have any disclosures relevant to this program.
William Bailey, MD does not have any discloses relevant to this program.
Roberta Bogaev, MD discloses the following, relevant to this program: Grant/Research Support—Thoratec Corporation and XDx, Inc.; Consultant Honoraria—Thoratec Corporation, Boston Scientific Corporation, and XDx, Inc; Speakers Bureau—Thoratec Corporation.
Paris Branford, MD does not have any discloses relevant to this program.
Jie Cheng, MD, PhD (Program Director) discloses the following, relevant to this program: Grant/Research Support—St. Jude Medical, Inc., Medtronic, Inc., and Boston Scientific Corporation; Consultant/Honoraria—St. Jude Medical, Inc.
Reynolds Delgado III, MD (Program Co-Director) discloses the following, relevant to this program: Consultant/Honoraria—Boston Scientific Corporation; Speaker’s Bureau—GlaxoSmithKline.
Sanjay Dixit, MD discloses the following, relevant to this program: Grant/Research Support—Boston Scientific Corporation; Consultant/Honoraria—BioSense Webster, Inc., Boston Scientific Corporation, and St. Jude Medical, Inc.
Igor D. Gregoric, MD does not have any discloses relevant to this program.
Douglas L. Mann, MD discloses the following, relevant to this program: Grant/Research Support—National Institutes of Health; Consultant/Honoraria—Acorn Cardiovascular, Inc. and Medtronic, Inc.; Scientific Advisory Board—ARMGO Pharma, Inc., Lpath, Inc., Nile Pharmaceuticals, and Cardiokine, Inc.
Emerson C. Perin, MD, PhD discloses the following, relevant to this program: Consultant/Honoraria—Cordis Corporation. In addition, he will discuss unlabeled or investigational uses of products.
In addition, peer reviewer, Patrick J. Hogan, MD has nothing to disclose relevant to this program.